首页> 美国卫生研究院文献>Marine Drugs >Facial Bone Reconstruction Using both Marine or Non-Marine Bone Substitutes: Evaluation of Current Outcomes in a Systematic Literature Review
【2h】

Facial Bone Reconstruction Using both Marine or Non-Marine Bone Substitutes: Evaluation of Current Outcomes in a Systematic Literature Review

机译:使用海洋或非海洋骨替代物进行面部骨重建:系统文献综述中当前结果的评估

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of the present investigation was to systematically analyse the literature on the facial bone reconstruction defect using marine collagen or not and to evaluate a predictable treatment for their clinical management. The revision has been performed by searched MEDLINE and EMBASE databases from 2007 to 2017. Clinical trials and animal in vitro studies that had reported the application of bone substitutes or not for bone reconstruction defect and using marine collagen or other bone substitute material were recorded following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The first selection involved 1201 citations. After screening and evaluation of suitability, 39 articles were added at the revision process. Numerous discrepancies among the papers about bone defects morphology, surgical protocols, and selection of biomaterials were found. All selected manuscripts considered the final clinical success after the facial bone reconstruction applying bone substitutes. However, the scientific evidence regarding the vantage of the appliance of a biomaterial versus autologous bone still remains debated. Marine collagen seems to favor the dimensional stability of the graft and it could be an excellent carrier for growth factors.
机译:本研究的目的是系统分析是否使用海洋胶原蛋白修复面部骨缺损的文献,并对其临床治疗评估可预测的治疗方法。修订是通过2007年至2017年搜索的MEDLINE和EMBASE数据库进行的。在临床试验和动物体外研究中,报道了报道了是否使用骨替代品治疗骨重建缺陷以及使用海洋胶原蛋白或其他骨替代材料的临床试验和动物体外研究,其记录如下。系统评价和荟萃分析(PRISMA)指南的报告项目。第一次选择涉及1201次引用。在筛选和评估适用性之后,在修订过程中添加了39篇文章。在论文中,关于骨缺损形态,手术方案和生物材料选择的许多差异被发现。所有选择的手稿均在应用骨替代物进行面部骨重建后,认为最终的临床成功。但是,关于使用生物材料与自体骨相比具有优势的科学证据仍然存在争议。海洋胶原蛋白似乎有利于移植物的尺寸稳定性,并且可能是生长因子的优良载体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号